Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Priyanka Agharkar"'
Autor:
David C. Gondek, Chong He, P. Jack Hoopes, Priyanka Agharkar, Curtis N Crane, Brian W. Pogue, Mark D. Savellano, Bin Chen
Publikováno v:
International Journal of Cancer. 123:695-701
Photodynamic therapy (PDT) is a light-based cancer treatment modality. Here we employed both in vivo and ex vivo fluorescence imaging to visualize vascular response and tumor cell survival after verteporfin-mediated PDT designed to target tumor vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::361d49bebfdcc9fafb1ad9f45463b906
https://doi.org/10.1002/ijc.23538
https://doi.org/10.1002/ijc.23538
Therapeutic enhancement of vascular-targeted photodynamic therapy by inhibiting proteasomal function
Publikováno v:
Cancer letters. 339(1)
Vascular-targeted photodynamic therapy (vPDT) is a novel vascular targeting modality based on site-directed delivery of a photosensitizer to tumor vasculature, which induces reactive oxygen species (ROS)-mediated vascular effects upon light activatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed5d435f34f2c1dfaa13f2caabec5924
https://pubmed.ncbi.nlm.nih.gov/23872275
https://pubmed.ncbi.nlm.nih.gov/23872275
Autor:
Bin, Chen, Curtis, Crane, Chong, He, David, Gondek, Priyanka, Agharkar, Mark D, Savellano, P Jack, Hoopes, Brian W, Pogue
Publikováno v:
International journal of cancer. 123(3)
Photodynamic therapy (PDT) is a light-based cancer treatment modality. Here we employed both in vivo and ex vivo fluorescence imaging to visualize vascular response and tumor cell survival after verteporfin-mediated PDT designed to target tumor vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90e6d34a583b6adc966b36a6a2067d6d
https://pubmed.ncbi.nlm.nih.gov/18498134
https://pubmed.ncbi.nlm.nih.gov/18498134
Publikováno v:
Pharmaceutical research. 25(8)
Photodynamic therapy (PDT), involving the combination of a photosensitizer and light, is being evaluated as a vascular disrupting therapy and drug delivery enhancement modality based on its effects on vascular perfusion and barrier function. Since tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0774958b6f6bd853cf03f6b05aa207ea
https://pubmed.ncbi.nlm.nih.gov/18446275
https://pubmed.ncbi.nlm.nih.gov/18446275
Autor:
Chong He, Priyanka Agharkar
Publikováno v:
Pharmaceutical Research; Aug2008, Vol. 25 Issue 8, p1873-1880, 8p